Previous close | 13,339.00 |
Open | 12,877.70 |
Bid | 12,566.41 x 100 |
Ask | 13,199.99 x 10000 |
Day's range | 12,877.70 - 12,877.70 |
52-week range | 7,452.75 - 13,844.99 |
Volume | |
Avg. volume | 296 |
Market cap | 12.239T |
Beta (5Y monthly) | 0.37 |
PE ratio (TTM) | 110.97 |
EPS (TTM) | 116.05 |
Earnings date | 30 Apr 2024 |
Forward dividend & yield | 87.85 (0.66%) |
Ex-dividend date | 14 Feb 2024 |
1y target est | N/A |
Novo Nordisk CEO Lars Jørgensen tells Yahoo Finance the company is confident about a robust GLP-1 sales year despite missing Wall Street estimates.
The Danish pharmaceutical giant, which became Europe’s most valuable company last year, said Wegovy sales jumped 106% in the first quarter.
Eli Lilly and Company (NYSE:LLY) Q1 2024 Earnings Call Transcript April 30, 2024 Eli Lilly and Company beats earnings expectations. Reported EPS is $2.58, expectations were $2.47. Operator: Ladies and gentlemen, thank you for standing by, and welcome to the Lilly Q1 2024 Earnings Call. At this time all participants are in a listen-only mode. […]